LifeMD, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $194.1 | $154.8 | $152.5 | $119.0 | $92.9 |
| Operating income | -$7.7 | -$20.4 | -$14.5 | -$43.4 | -$54.3 |
| Net income | $14.4 | -$21.4 | -$20.6 | -$45.5 | -$60.9 |
| Cash Flow Statement | |||||
| Free cash flow | $6.4 | $16.0 | $8.6 | -$23.3 | -$33.3 |
| Dividends | $3.1 | $3.1 | $3.1 | $3.1 | $0.9 |
| Share repurchases | $0.3 | — | — | — | — |
Shares outstanding 48.2M · Free float 79.7%
Annual filing data through FY ended December 31, 2025; float as of September 23, 2026.